news
stories from the front lines of discovery
From scientific breakthroughs to new open‑source tools, the Allen Institute’s work is reshaping how science is done—and who it’s for. Explore the latest news, stories, and highlights from across our research, partnerships, and open science efforts.
Brain Health accelerator to transform our understanding of brain disorders and develop new treatments
The global collaborative research initiative will initially target Alzheimer’s, Parkinson’s, Huntington’s disease, ALS, and Lewy body dementia

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

How immune cells detect different threat levels from salmonella
Your immune system has a tough job.
No items found.
news

5 unsolved mysteries about the brain
Can we understand our own brains? We have a long way to go, neuroscientists say.
brain science
news

Out of Balance | Tom Bumol’s life after lymphoma
What happens when an immunologist gets a life-threatening, immune-related disease? In Bumol’s case, he doubles down on his research.
No items found.

2 million-cell experiment traces how a mammal grows, cell by single cell
The very early days of growth, long before we are born, are a time of incredible development.
No items found.
news

New VR game lets you learn about cells by tossing them
The app teaches users the stages of cell division through interactions with 3D models of human cells
No items found.
news
Allen Institute adds former Washington governor, executives from JPMorgan Chase and Deloitte to Board of Directors
The Allen Institute today announced the appointment of three new members to its Board of Directors: Margaret Anderson, Managing Director with Deloitte...
No items found.
news
Data Stories | A tiny brain structure with an outsized role in neurological disorders
Emily Sylwestrak, Ph.D., has a hard time putting her finger on the exact moment her interest in science began. It’s always been there, for as long...
No items found.
news

Peter Skene | Transforming outcomes for patients
See how Peter Skene, director of Molecular Biology and Biochemistry at the Allen Institute for Immunology is working to answer this question and...
No items found.
news

New CRISPR-based technique in mice upends rules of genetic inheritance
The way we inherit genes is responsible for much of humanity’s incredible diversity.
No items found.
news
Out of Balance | Linda's life with RA
Linda Sloate is one of more than a million people in this country living with rheumatoid arthritis
cell science
No results found, try reducing your search parameters.
press & media contact
Get in touch for media inquiries and resources for covering science at the scale of greatest impact.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
What Causes Alzheimer’s? Scientists Are Rethinking the Answer
Scientists have long held onto the idea that sticky blobs of proteins sitting between brain cells are the cause of Alzheimer’s disease. Now, however, many are turning their attention to deeper dysfunctions happening within cells.
Seattle researchers lead ambitious project to map the human brain
We could be on the cusp of breakthrough treatments for brain diseases, from Alzheimer's Disease to depression and ADHD. Local scientists from the Allen Institute for Brain Science are spearheading a five-year project to map the human brain.
NIH launches the next stage of its ‘human genome project’ for the brain
The National Institutes of Health on Thursday announced more than $600 million in fresh funding for an expansive and ongoing push to unravel the mysteries of the human brain, bankrolling efforts to create a detailed map of the whole brain, and devise new ways to target therapeutics and other molecules to specific brain cell populations.
Data Trove Released by Seattle Alzheimer’s Disease Brain Cell Atlas
Neuroscientists at the Allen Institute for Brain Science and their collaborators have released their first research data set on Alzheimer’s disease, in which they categorized cell types based on gene activity. The team hope this approach could ultimately identify new targets for better therapies.
No results found, try reducing your search parameters.


